Research in lung disease – What are we doing?
Research offers hope and undisputed benefits for improving outcomes in lung diseases. In 2016, Lung Foundation Australia funded 29 research projects that studied both respiratory and thoracic oncology conditions and reached a significant funding milestone of $2.25 million, an increase of 47 percent since 2015.
Lung Foundation Australia has identified four priority areas to help us focus our research strategy into areas where we can make the biggest impact for those living with a lung condition. These include Chronic Obstructive Pulmonary Disease (COPD), lung cancer and rare lung diseases such as Idiopathic Pulmonary Fibrosis (IPF), bronchiectasis and Childhood Interstitial Lung Disease. We fund research that aims to make a difference and every application we receive for funding is peer-reviewed to find the research projects that will have the biggest impact. We have recently opened five respiratory awards for our 2018 funding round, with our oncology awards opening on 1 August this year. Lung Foundation Australia is committed to increase our award funding into lung disease research to $5 million per year by 2020. To find out more about our research awards and research platforms visit